Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.1 USD | +1.63% | -0.82% | +109.04% |
May. 16 | HC Wainwright Initiates Dianthus Therapeutics With Buy Rating, $40 Price Target | MT |
May. 10 | Wedbush Adjusts Dianthus Therapeutics' Price Target to $38 From $33, Keeps Outperform Rating | MT |